January 30, 2019
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Read More
January 30, 2019
A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.
Read More
January 30, 2019
A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.
Read More
January 30, 2019
Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy
Read More
January 30, 2019
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
Read More
January 30, 2019
Current Treatment of HCV Infection After HSCT
Read More
January 30, 2019
Current Treatment of HCV Infection After HSCT
Read More
January 30, 2019
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
Read More
January 30, 2019
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer’s Disease
Read More
January 30, 2019
MORE – Monitoring Revlimid – Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry
Read More
Load More
X